BioSpace News Archive

Drug Development

Tosk Reports Initiation of POC Human Studies

Tosk, Inc. reported today the completion of Phase 1 safety trials and the initiation of POC studies in human cancer patients for the prevention of mucositis side effects using its drug TK-90.

January 4, 2018
·
2 min read
Biotech Beach

NuVasive Gets Expanded FDA OK, Launches Interbody Fusion Devices

The launch and updated claims follow NuVasive’s September 2017 acquisition of Vertera Spine.

January 4, 2018
·
4 min read
BioMidwest

Abbott Gains Ground as Revolutionary Continuous Glucose Monitoring System Wins Medicare Coverage

The system is the only CGM system recognized by Medicare that requires no user calibration whatsoever.

January 4, 2018
·
7 min read
Business

EyeGate Promotes Sarah Romano to Chief Financial Officer

Sarah Romano, elevated from Interim CFO, will lead finance effort during transition to commercialization phase.

January 4, 2018
·
4 min read
Sealantis Receives CE Marking for Seal-G Surgical Sealant for GI Procedures

The CE will allow to market the product in the Europe and additional other countries.

January 4, 2018
·
2 min read
Business

Tarveda Therapeutics Appoints Brian Roberts as Chief Financial Officer

Mr. Roberts has nearly 25 years of finance, capital markets and operations experience spanning the life sciences, medtech and media industries with a proven track record of delivering positive results, financing companies and driving shareholder value.

January 4, 2018
·
4 min read
Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split

Scythian has approximately 5.43 million common shares currently outstanding, and after giving effect to the maximum proposed eight (8) for one (1) stock split, Scythian will have approximately 43.4 million common shares outstanding.

January 4, 2018
·
3 min read
Business

Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer

Mr. Wilson joins Crinetics from Cidara Therapeutics, where he was Vice President of Finance and Accounting and Chief Accounting Officer.

January 4, 2018
·
2 min read
Pharm Country

VenatoRx Pharmaceuticals Receives Award for up to $16 Million from DTRA to Develop a Novel, First-in-Class Antibiotic as Countermeasure against Potential Drug-Resistant Biodefense Category A/B Respiratory Pathogens

VenatoRx announced that it has been awarded up to $16 million from the Defense Threat Reduction Agency (DTRA), an agency of the U.S. Department of Defense.

January 4, 2018
·
2 min read
Business

Peli BioThermal Hires Dominic Hyde as New VP of Credo on Demand

With more than 23 years engineering expertise and leadership experience, Hyde will manage the worldwide expansion of Peli BioThermal’s Credo on Demand rental program.

January 4, 2018
·
2 min read